Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Surrallés J[au]:

Search results

Items: 1 to 50 of 105

1.

Functional Comparison of XPF Missense Mutations Associated to Multiple DNA Repair Disorders.

Marín M, Ramírez MJ, Carmona MA, Jia N, Ogi T, Bogliolo M, Surrallés J.

Genes (Basel). 2019 Jan 17;10(1). pii: E60. doi: 10.3390/genes10010060.

2.

Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma.

Toptan T, Brusadelli MG, Turpin B, Witte DP, Surrallés J, Velleuer E, Schramm M, Dietrich R, Brakenhoff RH, Moore PS, Chang Y, Wells SI.

PLoS One. 2018 Dec 27;13(12):e0209235. doi: 10.1371/journal.pone.0209235. eCollection 2018.

3.

Therapeutic research in the crystal chromosome disease Fanconi anemia.

Minguillón J, Surrallés J.

Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt A):104-108. doi: 10.1016/j.mrgentox.2018.05.012. Epub 2018 May 7. Review.

PMID:
30389152
4.

In Memory of Professor Adayapalam T Natarajan.

Balajee AS, Palitti F, Surrallés J, Hande MP.

Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt A):1-2. doi: 10.1016/j.mrgentox.2018.04.008. Epub 2018 May 7. No abstract available.

PMID:
30389151
5.

Mutations in TOP3A Cause a Bloom Syndrome-like Disorder.

Martin CA, Sarlós K, Logan CV, Thakur RS, Parry DA, Bizard AH, Leitch A, Cleal L, Ali NS, Al-Owain MA, Allen W, Altmüller J, Aza-Carmona M, Barakat BAY, Barraza-García J, Begtrup A, Bogliolo M, Cho MT, Cruz-Rojo J, Dhahrabi HAM, Elcioglu NH; GOSgene, Gorman GS, Jobling R, Kesterton I, Kishita Y, Kohda M, Le Quesne Stabej P, Malallah AJ, Nürnberg P, Ohtake A, Okazaki Y, Pujol R, Ramirez MJ, Revah-Politi A, Shimura M, Stevens P, Taylor RW, Turner L, Williams H, Wilson C, Yigit G, Zahavich L, Alkuraya FS, Surralles J, Iglesias A, Murayama K, Wollnik B, Dattani M, Heath KE, Hickson ID, Jackson AP.

Am J Hum Genet. 2018 Sep 6;103(3):456. doi: 10.1016/j.ajhg.2018.08.012. No abstract available.

6.

Mutations in TOP3A Cause a Bloom Syndrome-like Disorder.

Martin CA, Sarlós K, Logan CV, Thakur RS, Parry DA, Bizard AH, Leitch A, Cleal L, Ali NS, Al-Owain MA, Allen W, Altmüller J, Aza-Carmona M, Barakat BAY, Barraza-García J, Begtrup A, Bogliolo M, Cho MT, Cruz-Rojo J, Dhahrabi HAM, Elcioglu NH; GOSgene, Gorman GS, Jobling R, Kesterton I, Kishita Y, Kohda M, Le Quesne Stabej P, Malallah AJ, Nürnberg P, Ohtake A, Okazaki Y, Pujol R, Ramirez MJ, Revah-Politi A, Shimura M, Stevens P, Taylor RW, Turner L, Williams H, Wilson C, Yigit G, Zahavich L, Alkuraya FS, Surralles J, Iglesias A, Murayama K, Wollnik B, Dattani M, Heath KE, Hickson ID, Jackson AP.

Am J Hum Genet. 2018 Aug 2;103(2):221-231. doi: 10.1016/j.ajhg.2018.07.001. Epub 2018 Jul 26. Erratum in: Am J Hum Genet. 2018 Sep 6;103(3):456.

7.

From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia.

Krausz C, Riera-Escamilla A, Chianese C, Moreno-Mendoza D, Ars E, Rajmil O, Pujol R, Bogliolo M, Blanco I, Rodríguez I, Badell I, Ruiz-Castañé E, Surrallés J.

Genet Med. 2019 Jan;21(1):189-194. doi: 10.1038/s41436-018-0037-1. Epub 2018 Jun 14.

PMID:
29904161
8.

Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1.

Hernández G, Ramírez MJ, Minguillón J, Quiles P, Ruiz de Garibay G, Aza-Carmona M, Bogliolo M, Pujol R, Prados-Carvajal R, Fernández J, García N, López A, Gutiérrez-Enríquez S, Diez O, Benítez J, Salinas M, Teulé A, Brunet J, Radice P, Peterlongo P, Schindler D, Huertas P, Puente XS, Lázaro C, Pujana MÀ, Surrallés J.

Nat Commun. 2018 Mar 6;9(1):967. doi: 10.1038/s41467-018-03433-3.

9.

Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.

Reina-Castillón J, Pujol R, López-Sánchez M, Rodríguez-Santiago B, Aza-Carmona M, González JR, Casado JA, Bueren JA, Sevilla J, Badel I, Català A, Beléndez C, Dasí MÁ, Díaz de Heredia C, Soulier J, Schindler D, Pérez-Jurado LA, Surrallés J.

Blood Adv. 2017 Jan 23;1(5):319-329. doi: 10.1182/bloodadvances.2016000943. eCollection 2017 Jan 24. Erratum in: Blood Adv. 2017 Jul 31;1(18):1368.

10.

Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.

Catucci I, Osorio A, Arver B, Neidhardt G, Bogliolo M, Zanardi F, Riboni M, Minardi S, Pujol R, Azzollini J, Peissel B, Manoukian S, De Vecchi G, Casola S, Hauke J, Richters L, Rhiem K, Schmutzler RK, Wallander K, Törngren T, Borg Å, Radice P, Surrallés J, Hahnen E, Ehrencrona H, Kvist A, Benitez J, Peterlongo P.

Genet Med. 2018 Apr;20(4):452-457. doi: 10.1038/gim.2017.123. Epub 2017 Aug 24.

PMID:
28837162
11.

Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.

Bogliolo M, Bluteau D, Lespinasse J, Pujol R, Vasquez N, d'Enghien CD, Stoppa-Lyonnet D, Leblanc T, Soulier J, Surrallés J.

Genet Med. 2018 Apr;20(4):458-463. doi: 10.1038/gim.2017.124. Epub 2017 Aug 24.

PMID:
28837157
12.

Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients.

Río P, Navarro S, Guenechea G, Sánchez-Domínguez R, Lamana ML, Yañez R, Casado JA, Mehta PA, Pujol MR, Surrallés J, Charrier S, Galy A, Segovia JC, Díaz de Heredia C, Sevilla J, Bueren JA.

Blood. 2017 Sep 28;130(13):1535-1542. doi: 10.1182/blood-2017-03-774174. Epub 2017 Aug 11.

13.

Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.

Knies K, Inano S, Ramírez MJ, Ishiai M, Surrallés J, Takata M, Schindler D.

J Clin Invest. 2017 Aug 1;127(8):3013-3027. doi: 10.1172/JCI92069. Epub 2017 Jul 10.

14.

Activation of the Fanconi anemia/BRCA pathway at low doses of ionization radiation.

Bosch PC, Bogliolo M, Surrallés J.

Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:9-13. doi: 10.1016/j.mrgentox.2015.06.010. Epub 2015 Jun 17.

PMID:
26520367
15.

Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.

Belo H, Silva G, Cardoso BA, Porto B, Minguillon J, Barbot J, Coutinho J, Casado JA, Benedito M, Saturnino H, Costa E, Bueren JA, Surralles J, Almeida A.

PLoS One. 2015 Oct 14;10(10):e0139740. doi: 10.1371/journal.pone.0139740. eCollection 2015.

16.

Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.

Bogliolo M, Surrallés J.

Curr Opin Genet Dev. 2015 Aug;33:32-40. doi: 10.1016/j.gde.2015.07.002. Epub 2015 Aug 6. Review.

PMID:
26254775
17.

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, Marin M, Damiola F, Bernard L, Pensotti V, Volorio S, Dall'Olio V, Meindl A, Bartram C, Sutter C, Surowy H, Sornin V, Dondon MG, Eon-Marchais S, Stoppa-Lyonnet D, Andrieu N, Sinilnikova OM; GENESIS, Mitchell G, James PA, Thompson E; kConFab; SWE-BRCA, Marchetti M, Verzeroli C, Tartari C, Capone GL, Putignano AL, Genuardi M, Medici V, Marchi I, Federico M, Tognazzo S, Matricardi L, Agata S, Dolcetti R, Della Puppa L, Cini G, Gismondi V, Viassolo V, Perfumo C, Mencarelli MA, Baldassarri M, Peissel B, Roversi G, Silvestri V, Rizzolo P, Spina F, Vivanet C, Tibiletti MG, Caligo MA, Gambino G, Tommasi S, Pilato B, Tondini C, Corna C, Bonanni B, Barile M, Osorio A, Benitez J, Balestrino L, Ottini L, Manoukian S, Pierotti MA, Renieri A, Varesco L, Couch FJ, Wang X, Devilee P, Hilbers FS, van Asperen CJ, Viel A, Montagna M, Cortesi L, Diez O, Balmaña J, Hauke J, Schmutzler RK, Papi L, Pujana MA, Lázaro C, Falanga A, Offit K, Vijai J, Campbell I, Burwinkel B, Kvist A, Ehrencrona H, Mazoyer S, Pizzamiglio S, Verderio P, Surralles J, Rogan PK, Radice P.

Hum Mol Genet. 2015 Sep 15;24(18):5345-55. doi: 10.1093/hmg/ddv251. Epub 2015 Jun 30.

18.

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L.

Gastroenterology. 2015 Sep;149(3):563-6. doi: 10.1053/j.gastro.2015.05.056. Epub 2015 Jun 5.

19.

Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.

Aulinas A, Ramírez MJ, Barahona MJ, Valassi E, Resmini E, Mato E, Santos A, Crespo I, Bell O, Surrallés J, Webb SM.

PLoS One. 2015 Mar 23;10(3):e0120185. doi: 10.1371/journal.pone.0120185. eCollection 2015.

20.

Savior siblings and Fanconi anemia: analysis of success rates from the family's perspective.

Trujillo JP, Surralles J.

Genet Med. 2015 Nov;17(11):935-8. doi: 10.1038/gim.2014.206. Epub 2015 Feb 12.

PMID:
25674777
21.

Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs.

Liu GH, Suzuki K, Li M, Qu J, Montserrat N, Tarantino C, Gu Y, Yi F, Xu X, Zhang W, Ruiz S, Plongthongkum N, Zhang K, Masuda S, Nivet E, Tsunekawa Y, Soligalla RD, Goebl A, Aizawa E, Kim NY, Kim J, Dubova I, Li Y, Ren R, Benner C, Del Sol A, Bueren J, Trujillo JP, Surralles J, Cappelli E, Dufour C, Esteban CR, Belmonte JCI.

Nat Commun. 2014 Jul 7;5:4330. doi: 10.1038/ncomms5330.

22.

Targeted gene therapy and cell reprogramming in Fanconi anemia.

Rio P, Baños R, Lombardo A, Quintana-Bustamante O, Alvarez L, Garate Z, Genovese P, Almarza E, Valeri A, Díez B, Navarro S, Torres Y, Trujillo JP, Murillas R, Segovia JC, Samper E, Surralles J, Gregory PD, Holmes MC, Naldini L, Bueren JA.

EMBO Mol Med. 2014 Jun;6(6):835-48. doi: 10.15252/emmm.201303374. Epub 2014 Apr 6.

23.

Telomere length analysis in Cushing's syndrome.

Aulinas A, Ramírez MJ, Barahona MJ, Valassi E, Resmini E, Mato E, Santos A, Crespo I, Bell O, Surrallés J, Webb SM.

Eur J Endocrinol. 2014 Jul;171(1):21-9. doi: 10.1530/EJE-14-0098. Epub 2014 Apr 17.

PMID:
24743394
24.

Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles.

Osorio A, Bogliolo M, Fernández V, Barroso A, de la Hoya M, Caldés T, Lasa A, Ramón y Cajal T, Santamariña M, Vega A, Quiles F, Lázaro C, Díez O, Fernández D, González-Sarmiento R, Durán M, Piqueras JF, Marín M, Pujol R, Surrallés J, Benítez J.

Hum Mutat. 2013 Dec;34(12):1615-8. doi: 10.1002/humu.22438. Epub 2013 Oct 7.

PMID:
24027083
25.

Telomeres and endocrine dysfunction of the adrenal and GH/IGF-1 axes.

Aulinas A, Ramírez MJ, Barahona MJ, Mato E, Bell O, Surrallés J, Webb SM.

Clin Endocrinol (Oxf). 2013 Dec;79(6):751-9. doi: 10.1111/cen.12310. Epub 2013 Sep 4. Review.

PMID:
23937625
26.

Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A, Trujillo JP, Minguillón J, Ramírez MJ, Pujol R, Casado JA, Baños R, Rio P, Knies K, Zúñiga S, Benítez J, Bueren JA, Jaspers NG, Schärer OD, de Winter JP, Schindler D, Surrallés J.

Am J Hum Genet. 2013 May 2;92(5):800-6. doi: 10.1016/j.ajhg.2013.04.002. Epub 2013 Apr 25.

27.

Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients.

Joksic I, Vujic D, Guc-Scekic M, Leskovac A, Petrovic S, Ojani M, Trujillo JP, Surralles J, Zivkovic M, Stankovic A, Slijepcevic P, Joksic G.

Genome Integr. 2012 Sep 14;3(1):6. doi: 10.1186/2041-9414-3-6.

28.

On the role of FAN1 in Fanconi anemia.

Trujillo JP, Mina LB, Pujol R, Bogliolo M, Andrieux J, Holder M, Schuster B, Schindler D, Surrallés J.

Blood. 2012 Jul 5;120(1):86-9. doi: 10.1182/blood-2012-04-420604. Epub 2012 May 18.

29.

Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage.

Castillo P, Bogliolo M, Surralles J.

DNA Repair (Amst). 2011 May 5;10(5):518-25. doi: 10.1016/j.dnarep.2011.02.007. Epub 2011 Apr 5.

PMID:
21466974
30.

Exploring the link between MORF4L1 and risk of breast cancer.

Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, Kühl J, Neveling K, Schindler D, Ramírez MJ, Castellà M, Hernández G; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Davidson R, Ong KR, Cook J, Douglas F, Hodgson S, Brewer C, Morrison PJ, Porteous M, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Pasini B, Ottini L, Putignano AL, Savarese A, Bernard L, Radice P, Healey S, Spurdle A, Chen X, Beesley J; kConFab, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Asperen CJ, Bodmer D, Ausems MG, van Os TA, Blok MJ, Meijers-Heijboer HE, Hogervorst FB; HEBON, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR; SWE-BRCA, Harbst K, Borg A, Rantala J, Barbany-Bustinza G, Ehrencrona H, Stenmark-Askmalm M, Kaufman B, Laitman Y, Milgrom R, Friedman E, Domchek SM, Nathanson KL, Rebbeck TR, Johannsson OT, Couch FJ, Wang X, Fredericksen Z, Cuadras D, Moreno V, Pientka FK, Depping R, Caldés T, Osorio A, Benítez J, Bueren J, Heikkinen T, Nevanlinna H, Hamann U, Torres D, Caligo MA, Godwin AK, Imyanitov EN, Janavicius R; GEMO Study Collaborators, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Ferrer SF, Collonge-Rame MA, Mortemousque I, McGuffog L, Chenevix-Trench G, Pereira-Smith OM, Antoniou AC, Cerón J, Tominaga K, Surrallés J, Pujana MA.

Breast Cancer Res. 2011 Apr 5;13(2):R40. doi: 10.1186/bcr2862.

31.

Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation through tankyrase1-dependent manner.

Lyakhovich A, Ramirez MJ, Castellanos A, Castella M, Simons AM, Parvin JD, Surralles J.

Genome Integr. 2011 Feb 12;2(1):4. doi: 10.1186/2041-9414-2-4.

32.

Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Castella M, Pujol R, Callén E, Trujillo JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benítez J, Porto B, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Torrent M, Estella J, Dasí A, Rodríguez-Villa A, Gómez P, Barbot J, Tapia M, Molinés A, Figuera A, Bueren JA, Surrallés J.

Blood. 2011 Apr 7;117(14):3759-69. doi: 10.1182/blood-2010-08-299917. Epub 2011 Jan 27.

33.

Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.

Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Estella J, Dasí Á, Rodríguez-Villa A, Gómez P, Tapia M, Molinés A, Figuera Á, Bueren JA, Surrallés J.

J Med Genet. 2011 Apr;48(4):242-50. doi: 10.1136/jmg.2010.084210. Epub 2011 Jan 7.

PMID:
21217111
34.

Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.

Valeri A, Alonso-Ferrero ME, Río P, Pujol MR, Casado JA, Pérez L, Jacome A, Agirre X, Calasanz MJ, Hanenberg H, Surrallés J, Prosper F, Albella B, Bueren JA.

PLoS One. 2010 Dec 28;5(12):e15525. doi: 10.1371/journal.pone.0015525.

35.

Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells.

Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P.

Mutagenesis. 2011 Jan;26(1):125-32. doi: 10.1093/mutage/geq052. Review.

PMID:
21164193
36.

Epidemiology of rare anaemias in Europe.

Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surrallés J, Castella M, Heimpel H, Hill A, Corrons JL.

Adv Exp Med Biol. 2010;686:375-96. doi: 10.1007/978-90-481-9485-8_22. Review.

PMID:
20824457
37.

Constitutive activation of caspase-3 and Poly ADP ribose polymerase cleavage in fanconi anemia cells.

Lyakhovich A, Surrallés J.

Mol Cancer Res. 2010 Jan;8(1):46-56. doi: 10.1158/1541-7786.MCR-09-0373. Epub 2010 Jan 12.

38.

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Raya A, Rodríguez-Pizà I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castellà M, Río P, Sleep E, González F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surrallés J, Bueren J, Izpisúa Belmonte JC.

Nature. 2009 Jul 2;460(7251):53-9. doi: 10.1038/nature08129. Epub 2009 May 31.

39.

Laser confocal microscopy analysis of human interphase nuclei by three-dimensional FISH reveals dynamic perinucleolar clustering of telomeres.

Ramírez MJ, Surrallés J.

Cytogenet Genome Res. 2008;122(3-4):237-42. doi: 10.1159/000167809. Epub 2009 Jan 30.

PMID:
19188692
40.

Role of GST and NAT2 polymorphisms in thyroid cancer.

Hernández A, Xamena N, Surrallés J, Galofré P, Velázquez A, Creus A, Marcos R.

J Endocrinol Invest. 2008 Nov;31(11):1025-31.

PMID:
19169061
41.

Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Surralles J, Castella M, van der Wal JE, Wennerberg J, Califano J, Velleuer E, Dietrich R, Ebell W, Bloemena E, Joenje H, Leemans CR, Brakenhoff RH.

J Natl Cancer Inst. 2008 Nov 19;100(22):1649-53. doi: 10.1093/jnci/djn366. Epub 2008 Nov 11.

42.

Quick two-dimensional differential in gel electrophoresis-based method to determine length and secondary structures of telomeric DNA.

Lyakhovich A, Bech-Serra JJ, Canals F, Surralles J.

Anal Biochem. 2009 Jan 15;384(2):356-8. doi: 10.1016/j.ab.2008.09.046. Epub 2008 Oct 5.

PMID:
18938127
43.

In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.

Río P, Meza NW, González-Murillo A, Navarro S, Alvarez L, Surrallés J, Castella M, Guenechea G, Segovia JC, Hanenberg H, Bueren JA.

Blood. 2008 Dec 15;112(13):4853-61. doi: 10.1182/blood-2008-05-156356. Epub 2008 Sep 23.

44.

Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile.

Hernández A, Xamena N, Surrallés J, Sekaran C, Tokunaga H, Quinteros D, Creus A, Marcos R.

Mutat Res. 2008 Jan 1;637(1-2):80-92. Epub 2007 Jul 22.

PMID:
17850829
45.

FANCD2 depletion sensitizes cancer cells repopulation ability in vitro.

Lyakhovich A, Surralles J.

Cancer Lett. 2007 Oct 28;256(2):186-95. Epub 2007 Jul 23.

PMID:
17643815
46.

Telomere length modulates human radiation sensitivity in vitro.

Castella M, Puerto S, Creus A, Marcos R, Surralles J.

Toxicol Lett. 2007 Jul 30;172(1-2):29-36. Epub 2007 May 25.

PMID:
17604920
47.

New roads to FA/BRCA pathway: H2AX.

Lyakhovich A, Surrallés J.

Cell Cycle. 2007 May 2;6(9):1019-23. Epub 2007 May 1.

PMID:
17471025
48.

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surralles J, Casado JA, Bueren J, Dasi A, Soulier J, Gluckman E, Zwaan CM, van Spaendonk R, Pals G, de Winter JP, Joenje H, Grompe M, Auerbach AD, Hanenberg H, Schindler D.

Am J Hum Genet. 2007 May;80(5):895-910. Epub 2007 Apr 6. Erratum in: Am J Hum Genet. 2007 Jul;81(1):196.

49.

A DIGE-based approach to study interacting proteins.

Lyakhovich A, Canals F, Nosov M, Surralles J.

J Biochem Biophys Methods. 2007 Jun 10;70(4):693-5. Epub 2007 Mar 14.

PMID:
17433449
50.

Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.

Bogliolo M, Lyakhovich A, Callén E, Castellà M, Cappelli E, Ramírez MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, Surrallés J.

EMBO J. 2007 Mar 7;26(5):1340-51. Epub 2007 Feb 15.

Supplemental Content

Loading ...
Support Center